
BiotechTV - News Jefferies London: Olema Oncology more than doubled yesterday when Roche announced surprise data for its oral SERD - the CEO reacts and shares the development program for Olema's competing asset
Nov 19, 2025
Chapters
Transcript
Episode notes
